CHSCL CHS INC
Wholesale-Farm Product Raw Materials · Nasdaq · SEC CIK 823277 · Fiscal year ends 08/31
Financial factors as of 2026-08-31 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.6%
TTM net income YoY83.3%
TTM EPS YoY—
Revenue 3-yr CAGR-4.9%
Net income 3-yr CAGR-16.8%
Margins
Gross margin4.6%
Operating margin1.5%
Net margin2.8%
FCF margin2.9%
EBITDA margin3.2%
Returns
ROE9.6%
ROA5.6%
ROIC (approx.)4.4%
Asset turnover2.01x
Leverage & solvency
Liabilities / assets42.1%
Debt / equity0.18x
Current ratio1.68x
Interest coverage3.62x
Cash quality & payout
Operating cash flow / net income1.45x
Accruals ratio-2.5%
Payout ratio—
Capex / revenue1.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-08-31 | FY20252025-08-31 | FY20242024-08-31 | FY20232023-08-31 | FY20222022-08-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $39.23B | $35.46B | $39.26B | $45.59B | $47.79B |
| Cost of revenue | $37.44B | $34.33B | $37.51B | $43.21B | $45.66B |
| Gross profit | $1.79B | $1.14B | $1.75B | $2.38B | $2.13B |
| SG&A expense | $1.20B | $1.05B | $1.17B | $1.03B | $997.84M |
| Operating income | $591.88M | $90.75M | $584.36M | $1.34B | $1.13B |
| Interest expense | $163.63M | $146.08M | $104.06M | $137.44M | $114.16M |
| Pretax income | $1.13B | $614.77M | $1.10B | $2.01B | $1.81B |
| Income tax | $32.74M | $16.78M | -$4.87M | $107.66M | $132.12M |
| Net income | $1.10B | $597.92M | $1.10B | $1.90B | $1.68B |
| EBITDA | $1.27B | $742.18M | $1.15B | $1.88B | $1.59B |
| EPS (diluted) | — | — | — | — | — |
| Balance sheet | |||||
| Cash & equivalents | $263.60M | $327.83M | $794.87M | $1.84B | $903.47M |
| Short-term investments | — | $0 | $500.92M | $0 | — |
| Inventory | $3.98B | $3.27B | $3.07B | $3.22B | $3.65B |
| Current assets | $9.40B | $8.09B | $8.71B | $9.13B | $9.38B |
| PP&E, net | $5.38B | $5.50B | $5.18B | $4.87B | $4.74B |
| Goodwill | $239.44M | $239.44M | $179.98M | $179.98M | $179.98M |
| Intangibles | $82.01M | $94.41M | $42.10M | $46.98M | $53.16M |
| Total assets | $20.11B | $18.86B | $18.72B | $18.96B | $18.82B |
| Current liabilities | $5.61B | $5.28B | $5.40B | $5.90B | $6.95B |
| Short-term debt | $70.07M | $90.45M | $337.27M | $7.84M | $290.61M |
| Long-term debt | $1.98B | $1.75B | $1.82B | $1.82B | $1.67B |
| Total debt | $2.05B | $1.84B | $2.16B | $1.83B | $1.96B |
| Total liabilities | $8.47B | $7.78B | $7.95B | $8.51B | $9.36B |
| Shareholders' equity | $11.64B | $11.08B | $10.76B | $10.45B | $9.46B |
| Net debt | $1.79B | $1.51B | $1.37B | -$16.93M | $1.06B |
| Cash flow statement | |||||
| Operating cash flow | $1.58B | $635.79M | $1.27B | $3.28B | $1.95B |
| Capital expenditure | $463.26M | $728.58M | $808.76M | $564.52M | $354.44M |
| Free cash flow | $1.12B | -$92.79M | $464.12M | $2.72B | $1.59B |
| Investing cash flow | -$802.37M | -$880.60M | -$1.43B | -$950.19M | -$457.08M |
| Financing cash flow | -$796.85M | -$230.57M | -$814.25M | -$1.40B | -$1.11B |
| Depreciation & amortization | $677.14M | $651.43M | $569.89M | $539.52M | $461.97M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.